Evidence map›Paper›PMID 41229650›Full record

ArticleEuropean journal of case reports in internal medicine2025

Bilateral Renal Artery Embolization for Managing Uncontrolled Hypertension in A Haemodialysis Patient: An Alternative to Nephrectomy.

Humza Kunwer Naveed, Sumbal Nasir Mahmood, Ayesha Khalid, Osama Kunwer Naveed, Nauman Al Qamari, Sana Abid, Faeza Sohail

Abstract read
In one paragraph

Article in European journal of case reports in internal medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Humza Kunwer NaveedAga Khan University Hospital, Karachi, Pakistan.
Sumbal Nasir MahmoodZiauddin University, Karachi, Pakistan.
Ayesha KhalidAga Khan University Hospital, Karachi, Pakistan.
Osama Kunwer NaveedInternal Medicine, Southeast Health Medical Center, Dothan, USA.
Nauman Al QamariZiauddin University, Karachi, Pakistan.
Sana AbidZiauddin University, Karachi, Pakistan.
Faeza SohailZiauddin University, Karachi, Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients with end stage renal disease who have resistant or refractory hypertension (HTN) sometimes require bilateral nephrectomy to control their blood pressure. This treatment strategy is effective but is sometimes associated with morbidity and mortality and is costly. We report a case of a 65-year-old male on haemodialysis who developed refractory HTN, uncontrolled even with 7 antihypertensive drugs. He also had decompensated chronic liver disease and was a poor surgical candidate. He underwent bilateral renal artery chemoembolization as an alternative to bilateral nephrectomy and his BP significantly improved resulting in reduction of his antihypertensive therapy from 7 to 3 drugs. We report this case as an alternative approach to controlling resistant HTN in the haemodialysis population. LEARNING POINTS: Bilateral nephrectomy is an established option for blood pressure control in patients with end-stage renal disease and refractory hypertension, however, is associated with certain risks.Bilateral renal artery embolization is a minimally invasive alternative, particularly in patients who are poor surgical candidates.This approach may reduce the antihypertensive burden significantly and should be considered in multidisciplinary management of refractory hypertension in dialysis patients.

Indexed as

Bilateral renal artery embolizationhaemodialysisresistant hypertension

Identifiers

PMID41229650
PMCPMC12604891

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.